A maternal RSV vaccine to protect infants is one step closer to FDA approval

A maternal RSV vaccine to protect infants is one step closer to FDA approval https://ift.tt/EeduFAN

The candidate vaccine created by Pfizer would be approved for pregnant people to help prevent severe disease in infants from birth through 6 months.